Related Experiment Videos
Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients
The American Journal of Psychiatry
|July 1, 1985
Summary
Certain nortriptyline metabolites, not the drug itself, predict cardiac effects in elderly depressed patients. Specifically, E-10-hydroxynortriptyline levels indicated changes in heart conduction and repolarization during treatment.
Area of Science:
- Pharmacology
- Cardiology
- Geriatrics
Background:
- Nortriptyline is a common antidepressant used in elderly patients.
- Cardiovascular side effects are a concern with tricyclic antidepressants.
- Predicting these effects is crucial for patient safety.
Purpose of the Study:
- To identify biomarkers predicting cardiac conduction and repolarization effects during nortriptyline treatment in elderly depressed patients.
- To differentiate between drug-specific and metabolite-specific effects on cardiac function.
Main Methods:
- Electrocardiograms (ECGs) were performed before and during nortriptyline treatment in 18 elderly patients.
- Plasma levels of nortriptyline and its metabolite E-10-hydroxynortriptyline were measured.
- Correlation analysis was used to link plasma concentrations with ECG findings.
Main Results:
- Plasma concentrations of E-10-hydroxynortriptyline alone and combined with nortriptyline significantly distinguished patients with cardiac conduction/repolarization effects.
- Plasma nortriptyline levels, patient age, nortriptyline dosage, and baseline cardiovascular status did not predict these cardiac effects.
Conclusions:
- E-10-hydroxynortriptyline is a potential biomarker for predicting nortriptyline-induced cardiac effects in the elderly.
- Metabolite levels, rather than parent drug levels, may be more informative for assessing cardiovascular risk in this population.